Vertex Pharmaceuticals Competitors and Similar CompaniesClear all
Vertex Pharmaceuticals's competitors and similar companies include Eloxx Pharmaceuticals, Arcturus Therapeutics, Spirovant Sciences and Yumanity Therapeutics.
 Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. |  Eloxx Pharmaceuticals Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for rare and ultra-rare genetic diseases. |  Arcturus Therapeutics Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company. |  Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. |  Yumanity Therapeutics Yumanity Therapeutics (formerly known as Proteostasis Therapeutics) is a biopharmaceutical company developing therapeutics to treat diseases caused by an imbalance in the proteostasis network. | |
Founding Date | Founding Date 1989 | Founding Date 2013 | Founding Date 2013 | Founding Date 2016 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Waltham, US HQ Rehovot, IL | Locations San Diego, US HQ | Locations Philadelphia, US HQ | Locations Boston, US HQ | |
Employees | Employees 5,40013% increase | Employees 29 | Employees 170 | Employees 32 | Employees 4434% decrease |
Valuation ($) | Valuation ($) 117.5 b | Valuation ($) 1.9 k | Valuation ($) 576.3 m | Valuation ($) N/A | Valuation ($) 15.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $9.9b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $166.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $5.4m (FY, 2023) |
Net income | Net income $3.6b (FY, 2023) | Net income ($36.1m) (FY, 2022) | Net income ($29.7m) (FY, 2023) | Net income N/A | Net income ($14.1m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 2.4m | Total funding raised $ 30m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 82m |
For sources of this data, please see the company profile
View Company Profiles
Eloxx Pharmaceuticals
HQ
Waltham, US
Employees
29
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for rare and ultra-rare genetic diseases.
View companyArcturus Therapeutics
HQ
San Diego, US
Employees
170
Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company.
View companySpirovant Sciences
HQ
Philadelphia, US
Employees
32
Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
View companyYumanity Therapeutics
HQ
Boston, US
Employees
44↓ 34% decrease
Yumanity Therapeutics (formerly known as Proteostasis Therapeutics) is a biopharmaceutical company developing therapeutics to treat diseases caused by an imbalance in the proteostasis network.
View company